Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $49.1 million.

  • Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) fell 204.85% to $49.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.1 million, marking a year-over-year decrease of 204.85%. This contributed to the annual value of $50.1 million for FY2025, which is 19.53% down from last year.
  • As of Q4 2025, Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) stood at $49.1 million, which was down 204.85% from $49.5 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's 5-year Shares Outstanding (Diluted Average) high stood at $50.9 million for Q4 2021, and its period low was $49.1 million during Q4 2025.
  • In the last 5 years, Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) had a median value of $50.2 million in 2023 and averaged $50.2 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 59.25% in 2021, then crashed by 204.85% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) stood at $50.9 million in 2021, then decreased by 1.07% to $50.4 million in 2022, then decreased by 0.51% to $50.1 million in 2023, then decreased by 0.1% to $50.1 million in 2024, then dropped by 2.05% to $49.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $49.1 million in Q4 2025, compared to $49.5 million in Q3 2025 and $49.8 million in Q2 2025.